Nyrada Inc Annual Report 2020

NYRADA INC (ASX:NYR) 54 ASX Additional Information Corporate Governance Statement The Company’s corporate governance statement is located at the Company’s website: https://www.nyrada.com/site/investors/corporate-governance CHESS Depositary Interests The Company has CHESS Depositary Interests (CDIs) quoted on the Australian Securities Exchange (ASX) trading under the ASX code NYR. Each CDI represents an interest in one share of Class A common stock of the Company (Share). Legal title to the Shares underlying the CDIs is held by CHESS Depositary Nominees Pty Ltd (CDN), a wholly owned subsidiary of the ASX. The Company’s securities are not quoted on any other exchange. All information provided below is current as at 24 August 2020 except as otherwise stated. To avoid double-counting, the holding of Shares by CHESS Depositary Nominees Pty Limited (underpinning the CDIs on issue) have been disregarded in the presentation of the information below, unless otherwise stated. Distribution of CDIs Holding Ranges Holders Total Units % Issued Share Capital 1 to 1,000 10 2,673 0.97 1,001 to 5,000 212 741,345 20.48 5,001 to 10,000 162 1,415,584 15.65 10,001 to 100,000 544 23,483,851 52.56 100,001 and over 107 83,740,269 10.34 Total 1,035 109,383,722 100.00 Unmarketable parcels There are 35 shareholdings held with less than a marketable parcel, totaling 53,403 shares or 0.05% of the total CDIs. Unlisted securities a) 18,000,000 Performance Common Stock, with terms and conditions outlined in the Prospectus (released to the ASX on 14 January 2020) b) 1,725,656 Convertible Note Options, with an exercise price of $0.20 and expiry date of 30 November 2020 c) 8,000,000 Broker Options, with an exercise price of $0.20 and expiry date of 30 June 2024 d) 31,500,000 ESOP Options, with terms and conditions outlined in the Prospectus (released to the ASX on 14 January 2020) Distribution of Unlisted Securities (> 20% holding) Holder Performance Common Stock Convertible Note Options Broker Options ESOP Options % % % % NOXOPHARM LIMITED 66.67% ALTNIA HOLDING PTY LTD <I DIXON FAMILY A/C> 33.33% GOODRIDGE FOUNDATION PTY LTD <GOODRIDGE FOUNDATION A/C> 28.78% GOODRIDGE NOMINEES PTY LTD <THE GOODRIDGE FAMILY A/C> 28.78% ACNS CAPITAL MARKETS PTY LTD 25.00% GRAHAM KELLY 57.14%